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Increased susceptibility to infections is among the main safety concerns raised by
biological agents. We describe five cases of Whipple's disease diagnosed during
treatment with biological agents.
Methods
We retrospectively identified five cases of Whipple's disease diagnosed between
2003 and 2009 in patients treated with TNFα antagonists in five French hospitals.
Results
Five patients (four male; mean age: 50.4 years; range: 38–67) underwent biological
therapy according to prior diagnoses of rheumatoid arthritis (n = 2), ankylosing
spondylitis (n = 2), or spondyloarthropathy (n = 1). Biological therapy failed to
control the disease, which responded to appropriate antibiotics for Whipple's
disease. Retrospectively, clinical symptoms before biological therapy were
consistent with Whipple's disease. All five patients had favorable outcomes (mean
follow-up, 29 months [13–71]).
Conclusions
Biological therapy probably worsened preexisting Whipple's disease, triggering the
visceral disorders. Whipple's disease must be ruled out in patients with joint
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